四种生物制剂治疗克罗恩病相关淋巴瘤风险：一项上市后监测数据的真实世界研究
宋尧, 潘晨, 赵晓红, 杨鸿鸽, 李泽, 崔向丽
Lymphoma risk in the treatment of Crohn's disease with four biological agents: a real world analysis of post-marketing surveillance data
SONG Yao, PAN Chen, ZHAO Xiaohong, YANG Hongge, LI Ze, CUI Xiangli
中国临床药理学与治疗学
.
2024, (7): 768
-774
.
DOI: 10.12092/j.issn.1009-2501.2024.07.006
